Point-of-Care Diagnostics Market is expected to reach USD 78.5 billion by 2034

Point-of-care (POC) diagnostics refers to medical testing performed at or near the patient's location rather than in centralized laboratories. These tests deliver rapid, reliable results that aid clinical decision-making in real time. From blood glucose meters and pregnancy kits to COVID-19 antigen tests, cardiac markers, and infectious disease assays, POC diagnostics has become a critical part of global healthcare delivery.

Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73467

The market is expanding due to the rise in chronic diseases, infectious disease outbreaks, personalized medicine, and demand for faster diagnostics in both hospitals and home-care settings.

Market Overview
• Market Size (2024): USD 40.8 billion
• Forecast (2034): USD 78.5 billion
• CAGR (2025-2034): 6.8%

Key Highlights:
• COVID-19 testing accelerated POC adoption and raised public awareness.
• Chronic disease management (diabetes, cardiovascular disease) accounts for a major share.
• Advances in biosensors, microfluidics, and lab-on-chip devices are fueling innovation.
• Decentralized diagnostics models supported by telehealth and e-commerce distribution.

Segmentation Analysis
By Product Type:
• Glucose Monitoring Kits
• Infectious Disease Testing Kits (HIV, influenza, COVID-19, TB, etc.)
• Cardiac Marker Testing Devices
• Coagulation Testing Kits
• Pregnancy & Fertility Testing Kits
• Hematology & Blood Gas Testing Devices
• Urinalysis Testing Kits
• Others (cholesterol, cancer markers)

By Technology:
• Lateral Flow Assays (dominant due to pregnancy and COVID kits)
• Molecular Diagnostics (PCR-based, isothermal amplification)
• Immunoassays (ELISA-based rapid formats)
• Microfluidics & Lab-on-a-Chip Platforms

By Application:
• Diabetes Monitoring
• Cardiovascular Disease Detection
• Infectious Disease Management
• Oncology
• Prenatal & Fertility Testing
• Others (drug abuse testing, nephrology)

By End Use:
• Hospitals & Clinics
• Homecare Settings
• Ambulatory Surgical Centers
• Research Laboratories
• Others (military, remote healthcare, disaster settings)

Segmentation Summary:
Glucose monitoring dominates revenues, while infectious disease testing and molecular POC systems are the fastest-growing segments. Homecare and retail distribution channels are gaining importance.

Explore Full Report here: https://exactitudeconsultancy.com/reports/73467/point-of-care-diagnostics-market

Regional Analysis
North America
• Largest share (~42% in 2024).
• Strong adoption in chronic disease monitoring and infectious disease testing.
• FDA approvals and integration with telehealth platforms boosting growth.
Europe
• ~30% share.
• Germany, UK, and France leading in infectious disease and cardiac marker testing.
• EU investments in decentralized diagnostics and cross-border digital health integration.
Asia-Pacific
• Fastest-growing region with CAGR of ~8.1%.
• High infectious disease burden and rising diabetes prevalence in India and China.
• Increasing government funding for community-level diagnostic programs.
Latin America
• Brazil and Mexico lead adoption in both public and private health systems.
• Expanding use of POC kits for infectious diseases and maternal health.
Middle East & Africa
• Adoption growing with infectious disease control programs.
• GCC nations expanding investment in chronic disease diagnostics.
Regional Summary:
North America and Europe lead, but Asia-Pacific will experience the fastest growth due to high disease burden and scaling access programs.

Market Dynamics
Key Growth Drivers:
• Rising global burden of chronic diseases requiring frequent monitoring.
• Growing demand for rapid infectious disease testing.
• Expansion of telemedicine and e-commerce in diagnostics distribution.
• Technological advancements in biosensors, microfluidics, and AI integration.

Key Challenges:
• Variability in test accuracy compared to centralized labs.
• Reimbursement and regulatory complexities.
• Limited infrastructure for quality assurance in developing markets.
• Supply chain vulnerabilities, highlighted during COVID-19.

Latest Trends:
• Growth of AI-powered and smartphone-connected diagnostic kits.
• Expansion of molecular POC testing for precision medicine.
• Decentralization of diagnostics into pharmacies, retail clinics, and homes.
• Emerging focus on multi-analyte testing platforms for chronic and infectious diseases.

Get Your Exclusive Offer with up to 10% Discount : https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73467

Competitor Analysis
Major Players in the Market:
• Abbott Laboratories (i-STAT, FreeStyle glucose monitoring)
• Roche Diagnostics (Accu-Chek, cobas Liat molecular POC)
• Siemens Healthineers AG
• Danaher Corporation (Cepheid - GeneXpert POC molecular systems)
• Becton, Dickinson and Company (BD Veritor antigen testing)
• bioMérieux SA
• Chembio Diagnostics, Inc.
• Cardinal Health, Inc.
• EKF Diagnostics Holdings plc
• Trinity Biotech plc

Competitive Summary:
Abbott and Roche lead with glucose monitoring and infectious disease kits. Cepheid (Danaher) dominates molecular POC testing. BD and bioMérieux drive infectious disease detection. Competition is centered on accuracy, affordability, connectivity, and distribution reach.

Conclusion
The Point-of-Care Diagnostics Market, valued at USD 40.8 billion in 2024, is projected to reach USD 78.5 billion by 2034, growing at a CAGR of 6.8%.

Key Takeaways:
• Glucose monitoring and infectious disease testing dominate today, while molecular POC systems are the fastest-growing segment.
• North America and Europe lead adoption, while Asia-Pacific is the fastest-growing region.
• AI, smartphone connectivity, and lab-on-chip platforms will redefine the future of POC diagnostics.
• Expanding access through pharmacies, retail clinics, and telehealth will accelerate global adoption.

Over the next decade, point-of-care diagnostics will move from single-analyte kits to intelligent, connected, multi-disease platforms, reshaping global healthcare delivery toward faster, more decentralized, and patient-centered care.

This report is also available in the following languages : Japanese (ポイントオブケア診断市場), Korean (진료 시점 진단 시장), Chinese (即时诊断市场), French (Marché du diagnostic au point de service), German (Markt für Point-of-Care-Diagnostik), and Italian (Mercato della diagnostica point-of-care), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/reports/73467/point-of-care-diagnostics-market#request-a-sample

Our More Reports:

Fermenters and Bioreactors Market
https://exactitudeconsultancy.com/reports/73517/fermenters-and-bioreactors-market

Novel Spectrometry Market
https://exactitudeconsultancy.com/reports/73519/novel-spectrometry-market

Small Scale Bioreactors Market
https://exactitudeconsultancy.com/reports/73521/small-scale-bioreactors-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.